Retatrutide Dosing Guide:
Protocol, Reconstitution & Tracking

Complete evidence-based Retatrutide dosing protocol for 2026. Updated reconstitution steps, injection guidance, and cycle protocols.

⚠️ Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a licensed healthcare provider before starting any peptide or medication protocol.

⚡ Retatrutide Quick Reference

Common dose: 4,000–12,000 mcg  |  Frequency: Once weekly
Half-life: ~6 days  |  Category: GLP-1 / Weight Loss
Injection sites: Subcutaneous — abdomen, thigh, or upper arm

⚡ Use Free Retatrutide Calculator →

What is Retatrutide?

Retatrutide is a next-generation triple agonist targeting GIP, GLP-1, and glucagon receptors simultaneously — the most powerful weight loss compound in clinical development. Phase 2 trials by Eli Lilly demonstrated up to 24% body weight reduction, exceeding both semaglutide (~15%) and tirzepatide (~22%). Adding glucagon receptor activation further increases energy expenditure and fatty acid oxidation. Currently in Phase 3 trials; FDA approval expected 2026–2027. Compounded research versions available.

Benefits of Retatrutide

Dosing Protocols

Below are evidence-based Retatrutide dosing protocols for different experience levels and goals. Always start at the lowest effective dose and assess tolerance before increasing.

Research Starting Dose: 4 mg (4,000 mcg) weekly.
Phase 2 Efficacy Dose: 8 mg weekly — strongest results in trials.
Maximum Research Dose: 12 mg weekly.

Reconstitution Guide

Proper reconstitution is critical for accurate dosing. Follow these steps carefully:

1
Add 2 mL BAC water to 10 mg vial = 5,000 mcg/mL
2
4 mg = 0.80 mL | 8 mg = 1.60 mL
3
Refrigerate; use within 28 days

Dosing Reference Table

Use this table to determine your exact injection volume based on vial size and BAC water amount:

Vial SizeBAC WaterConcentrationLow Dose VolHigh Dose Vol
10 mg2 mL5,000 mcg/mL0.80 mL1.60 mL
10 mg4 mL2,500 mcg/mL1.60 mL3.20 mL

Injection Site Guide

Recommended sites: Subcutaneous — abdomen, thigh, or upper arm

Rotate injection sites to prevent scar tissue buildup. Clean the injection site with an alcohol swab before injecting. Use a 27-29 gauge insulin syringe for subcutaneous injections. Pinch the skin, insert needle at 45-90°, and inject slowly.

Storage Guidelines

Lyophilized (powder) form: Refrigerate at 36–46°F (2–8°C). Protect from light. Most peptides remain stable for 1–2 years unreconstituted.

Reconstituted solution: Refrigerate immediately after mixing. Use within 4 weeks typically. Do not freeze reconstituted peptides — this may damage the peptide structure.

Frequently Asked Questions

Q: What is retatrutide?
A: Triple agonist (GIP+GLP-1+Glucagon) in Phase 3 trials showing up to 24% weight loss.
Q: Dose used?
A: 4 mg, 8 mg, or 12 mg weekly per research protocols.
Q: Side effects?
A: Similar to GLP-1 agents: nausea, diarrhea, GI discomfort — potentially more pronounced.
Q: When FDA-approved?
A: Expected 2026–2027 if Phase 3 confirms Phase 2 results.
Q: Better than semaglutide?
A: Phase 2 data shows superior weight loss. Head-to-head Phase 3 data still pending.

Track Your Retatrutide Protocol with DoseIQ

📱 Track Every Dose with DoseIQ

The #1 peptide tracking app for iPhone. Calculate doses, log injections, set reminders, and track your progress.

⬇️ Download Free on App Store

Related Guides

Tirzepatide Guide →Semaglutide Guide →